HK2 and glioblastoma: Notably, glycolytic GBM cells show greater resistance to radiation; indeed, it has been demonstrated that downregulation of the glycolytic enzyme Hexokinase 2 (HK2) increases GBM sensitivity to radiotherapy (Figure 5A) (Vartanian et al., 2016; Zhou and Wahl, 2019).